Category: AngioDynamics Inc.
Here's a look at some of the top regulatory stories for medical device companies this week: FDA gives the green light to Stimwave's mini spinal cord stimulator; HeartFlow wins FDA OK for non-invasive FFR system; FDA warns AngioDynamics subsidiary Navilyst on hairs in PICC packaging; Philips defib updates spur ConMed electrode recall; FDA approves J&J spinal device for rare pediatric syndrome
The FDA issues a warning letter to AngioDynamics subsidiary Navilyst Medical Systems on reports that some of its catheters shipped with hairs in their packaging.
AngioDynamics revises its financial results back to the beginning of its 2012 fiscal year, saying it's still assessing its internal controls while getting improved visibility from a new ERP platform.
HeartWare International names Dr. Katrin Leadley to be its new chief medical officer following the retirement of Dr. David Hathaway.
, eLux Medical
, HeartWare International Inc.
, NxStage Medical Inc.
, Revolutions Medical Corp.
, Terumo Corp.
, X2 Biosystems
, AngioDynamics Inc.
AngioDynamics names Concert Medical president Howard Donnelly as chairman, replacing Vincent Bucci, who stepped down last month.
AngioDynamics (NSDQ:ANGO) said today that it tapped Concert Medical president Howard Donnelly to replace outgoing chairman Vincent Bucci.
Bucci, 1st named to the AngioDynamics board in 2007, was named chairman later that year. He stepped down in March.
AngioDynamics reports a profitable fiscal 3rd quarter and nearly doubles Wall Street's earnings forecast, but shares slide anyway.
AngioDynamics (NSDQ:ANGO) put some black ink in the ledger during its fiscal 3rd quarter and handily topped Wall Street's earnings forecast, but investors have remained unmoved, sending ANGO shares down 12% since its April 9 earnings release.
AngioDynamics wins a nearly $75 million judgment against erstwhile partner Biolitec AG over an alleged scheme to evade U.S legal jurisdiction.